Published in Healthcare Mergers, Acquisitions and Ventures Week, May 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Valeant Pharmaceuticals.
Report 1: Valeant Pharmaceuticals International (VRX) announced that it is developing an intranasal form of delivery for diazepam for the treatment of seizure emergencies in children and adults, in conjunction with researchers from the University of Minnesota.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.